HHS:NASDAQHarte Hanks, Inc. Analysis
Data as of 2026-04-08 - not real-time
$2.50
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook is bearish: the stock trades at $2.50, below its 20‑day (2.55), 50‑day (2.75) and 200‑day (3.25) simple moving averages, with a declining volume trend and a RSI of 44 indicating limited upside momentum. MACD shows a marginal bullish histogram but the line remains in negative territory, underscoring mixed short‑term signals.
Fundamentals suggest deep discount: forward earnings per share of $1.07 translates to a forward P/E of ~2.3, far below the industry average of ~30, while price‑to‑book (0.9) and price‑to‑sales (0.12) are also well under 1. However, revenue has contracted 15%, margins are negative, operating cash flow is –$1.7 M and debt‑to‑equity exceeds 100%, highlighting significant financial strain. The company reports no dividend and carries high leverage, making sustainability a concern despite the attractive valuation metrics.
Fundamentals suggest deep discount: forward earnings per share of $1.07 translates to a forward P/E of ~2.3, far below the industry average of ~30, while price‑to‑book (0.9) and price‑to‑sales (0.12) are also well under 1. However, revenue has contracted 15%, margins are negative, operating cash flow is –$1.7 M and debt‑to‑equity exceeds 100%, highlighting significant financial strain. The company reports no dividend and carries high leverage, making sustainability a concern despite the attractive valuation metrics.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below key moving averages
- Decreasing volume and modest RSI
- Support level near $2.22
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward earnings outlook improves valuation
- High leverage and negative cash flow
- Potential turnaround in revenue solutions segment
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Deep value relative to industry multiples
- Positive forward EPS indicating earnings recovery
- Diversified service portfolio that could benefit from post‑recession marketing spend
Key Metrics & Analysis
Financial Health
Revenue Growth-15.40%
Profit Margin-0.51%
P/E Ratio2.3
ROE-3.84%
ROA0.62%
Debt/Equity109.15
P/B Ratio0.9
Op. Cash Flow$-1735000
Free Cash Flow$590.5K
Industry P/E29.6
Technical Analysis
TrendBearish
RSI44.2
Support$2.22
Resistance$2.78
MA 20$2.55
MA 50$2.75
MA 200$3.25
MACDBullish
VolumeDecreasing
Fear & Greed Index85.23
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.69
Volatility46.85%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.